Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  132 results for ""Sodium-Glucose Transporter 2 Inhibitors""

Your Filters

Subject : biomarkers
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The effect of sodium-glucose cotransporter-2 inhibitors on inflammatory biomarkers: A meta-analysis of randomized controlled trials.

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2706-2721. Date of Electronic Publication: 2024 Apr 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Dapagliflozin reduces systemic inflammation in patients with type 2 diabetes without known heart failure.

  • Authors : Wang DD; Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA, USA.; Naumova AV

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/adverse effects ; Glucosides*/Glucosides*/Glucosides*/therapeutic use

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Jun 07; Vol. 23 (1), pp. 197. Date of Electronic Publication: 2024 Jun 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy.

  • Authors : Dihoum A; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, Scotland, UK.; Brown AJ

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Hypertrophy, Left Ventricular*/Hypertrophy, Left Ventricular*/Hypertrophy, Left Ventricular*/physiopathology

  • Source: BMC cardiovascular disorders [BMC Cardiovasc Disord] 2024 Jul 12; Vol. 24 (1), pp. 356. Date of Electronic Publication: 2024 Jul 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261

Record details

Read More Add to Saved list
×
Academic Journal

Dapagliflozin Reduces Urinary Kidney Injury Biomarkers in Chronic Kidney Disease Irrespective of Albuminuria Level.

  • Authors : Cho J; Division of Nephrology, Soonchunhyang University Seoul Hospital, Seoul, Korea.; Doo SW

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Albuminuria*/Albuminuria*/Albuminuria*/urine ; Albuminuria*/Albuminuria*/Albuminuria*/drug therapy

  • Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jun; Vol. 115 (6), pp. 1441-1449. Date of Electronic Publication: 2024 Mar 07.Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535

Record details

Read More Add to Saved list
×
Academic Journal

Association of type III collagen turnover with cardiovascular outcomes and impact with canagliflozin in the CANVAS Program: A post hoc analysis.

Subjects: Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Sep; Vol. 26 (9), pp. 4060-4068. Date of Electronic Publication: 2024 Jul 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

SGLT1 and SGLT2 inhibition, circulating metabolites, and cerebral small vessel disease: a mediation Mendelian Randomization study.

  • Authors : Lv Y; Department of Neurology, National Center for Neurological Disorders, National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China. .; 12 Wulumuqi Zhong Road, 200040, Shanghai, P. R. China. .

Subjects: Mendelian Randomization Analysis* ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 May 07; Vol. 23 (1), pp. 157. Date of Electronic Publication: 2024 May 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Connect Read More Add to Saved list
×
Academic Journal

Ketone body levels and its associations with cardiac markers following an acute myocardial infarction: a post hoc analysis of the EMMY trial.

  • Authors : Aziz F; Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.; Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Biomarkers*/Biomarkers*/Biomarkers*/blood

  • Source: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 Apr 27; Vol. 23 (1), pp. 145. Date of Electronic Publication: 2024 Apr 27.Publisher: BioMed Central Country of Publication: England NLM ID: 101147637 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2840

Record details

Read Online Read More Add to Saved list
×
Academic Journal

SGLT2 inhibitor dapagliflozin reduces proximal tubular cell damage biomarkers in patients with acute heart failure.

  • Authors : Gojaseni P; Division of Nephrology, Department of Medicine, Bhumibol Adulyadej Hospital, Directorate of Medical Services, Royal Thai Air Force, Bangkok, Thailand.; Wattanakul J

Subjects: Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use ; Biomarkers*/Biomarkers*/Biomarkers*/blood ; Glucosides*/Glucosides*/Glucosides*/therapeutic use

  • Source: Renal failure [Ren Fail] 2024 Dec; Vol. 46 (2), pp. 2373275. Date of Electronic Publication: 2024 Jul 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Connect Read More Add to Saved list
×
Academic Journal

Blood glucose levels and bodyweight change after dapagliflozin administration.

  • Authors : Kim H; College of Pharmacy, Sookmyung Women's University, Seoul, Korea.; Lee SH

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; Blood Glucose*/Blood Glucose*/Blood Glucose*/analysis ; Body Weight*

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2021 Sep; Vol. 12 (9), pp. 1594-1602. Date of Electronic Publication: 2021 Feb 28.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

Sodium-glucose cotransporter 2 inhibitors compared with other glucose-lowering drugs in Japan: Subanalyses of the CVD-REAL 2 Study.

  • Authors : Kohsaka S; Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.; Takeda M

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*prevention & control ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2021 Jan; Vol. 12 (1), pp. 67-73. Date of Electronic Publication: 2020 Jul 26.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

Read More Add to Saved list
×
  • 1-10 of  132 results for ""Sodium-Glucose Transporter 2 Inhibitors""